Limpar
111 resultados

Acesso aberto

Tipo do recurso

Ano de criação

Produção nacional

Revisado por pares

Áreas

Idioma

Editores

Artigo Acesso aberto Revisado por pares

R. Drimmel, A. Sozzetti, Klaus‐Peter Schröder, U. Bastian, M. Pinamonti, D. Jack, Missael Alejandro Hernández Huerta,

... A) of the well-known wide double star Albireo. By matching evolutionary tracks to the physical parameters of all three Albireo stars (beta Cyg Aa, Ac and B) as ... presence of a fourth, unseen, member of the Albireo system. Given the current photometric data it is ... allowing us to quantitatively assess the hypothesis that Albireo A and B form a physically bound and ... members of a common proper motion group with Albireo, though none anywhere as close by as the Albireo components A to B.

Tópico(s): Astro and Planetary Science

2021 - Oxford University Press | Monthly Notices of the Royal Astronomical Society

Artigo Acesso aberto Revisado por pares

U. Bastian, R. Antón,

Aims: We aim to clarify the nature of Albireo AB and specifically to decipher whether it is ... We also try to determine the mass of Albireo Aa. Methods: We scrutinize and compare the available ... astrometric data (from Hipparcos and Gaia DR2) of Albireo A and B, and we investigate the relative orbit of the pair Albireo Aa,Ac using orbit solutions based on ground-based interferometric measurements. Results: The mass of Albireo Aa (K3 II) is surprisingly small; only an ... an uncertainty of less than 2 mas/year. Albireo AB is therefore most probably an optical double. ...

Tópico(s): Historical Astronomy and Related Studies

2018 - EDP Sciences | Astronomy and Astrophysics

Artigo Revisado por pares

Jean–Frédéric Colombel, Paul Rutgeerts, William J. Sandborn, Mei Yang, Kathleen G. Lomax, Paul Pollack, Roopal Thakkar, Anne Camez, Naijun Chen, Jingdong Chao, Parvez Mulani,

... Advisory Boards and/or Consulting: Abbott, Acto-GeniX, Albireo Pharma, Astra Zeneca, Bayer Schering Pharma, Biogen Idec, ... Abbott Laboratories (fees paid to Mayo), AGI Therapeutics, Albireo, Alfa Wassermann, AM-Pharma, Amgen, Anaphore, Astellas Pharma, ...

Tópico(s): Eosinophilic Esophagitis

2010 - Lippincott Williams & Wilkins | The American Journal of Gastroenterology

Artigo Revisado por pares

Remo Panaccione, William Sandborn, Glenn L. Gordon, Scott Lee, Alan Safdi, Shahriar Sedghi, Brian Feagan, Stephen B. Hanauer, Ashish Kumar, Roberto Carcereri,

... Abbott Laboratories (fees paid to Mayo), AGI Therapeutics, Albireo, Alfa Wassermann, AM-Pharma, Amgen, Anaphore, Astellas Pharma, ... Consulting Abbott, Self: Consulting fee, Grant/Research Support Albireo Pharmaceuticals, Self: Consulting fee, Consulting Bristol-Myers Squibb ...

Tópico(s): Autoimmune and Inflammatory Disorders Research

2010 - Lippincott Williams & Wilkins | The American Journal of Gastroenterology

Carta Acesso aberto Revisado por pares

Elisabeth Krones, Wolfgang Erwa, Michael Trauner, Peter Fickert,

... grants from Falk. He consults for and advises Albireo, Genfit, Intercept, and Phenex. He is on the ... and Roche. He received grants from Intercept and Albireo. To the Editor: Well‐characterized preclinical animal models ...

Tópico(s): Pediatric Hepatobiliary Diseases and Treatments

2014 - Lippincott Williams & Wilkins | Hepatology

Artigo Revisado por pares

Jean‐Frédéric Colombel, Bruce E. Sands, Stephen B. Hanauer, Paul Rutgeerts, William J. Sandborn, Silvio Danese, Geert R. DʼHaens, Remo Panaccione, Serap Sankoh, Irving H. Fox, Asit Parikh, Catherine Milch, Brian G. Feagan,

... ActoGeniX NV, AGI Therapeutics Inc, Alba Therapeutics Corporation, Albireo, Alfa Wasserman, Amgen, AM-Pharma BV, Anaphore, Astellas ... Ore Pharmaceuticals, Cerimon Pharma, Genentech, Tillotts, Unity Pharmaceuticals, Albireo Pharma, Salix Pharma, Novo Nordisk, GSK, Astra Zeneca, ...

Tópico(s): Immunodeficiency and Autoimmune Disorders

2013 - Lippincott Williams & Wilkins | The American Journal of Gastroenterology

Carta Acesso aberto Revisado por pares

K Kozbial, Stephan Moser, Rémy Schwarzer, Hermann Laferl, Ramona Al‐Zoairy, Rudolf Stauber, Albert Friedrich Stättermayer, S. Beinhardt, Ivo Graziadei, C Freissmuth, A Maieron, Michael Gschwantler, Michael Straßer, Markus Peck-Radosalvjevic, Michael Trauner, Harald Hofer, Péter Ferenci,

... MSD and Roche. Michael Trauner: received grants from Albireo, Falk, Intercept, MSD, Takeda, honoraria for consulting from Albireo, AbbVie, Falk, Gilead, Janssen, MSD, Phenex, and Novartis, ...

Tópico(s): Liver Disease and Transplantation

2016 - Elsevier BV | Journal of Hepatology

Artigo

Sigurd Lax, Kristijan Skok, Peter Zechner, Harald H. Kessler, Norbert Kaufmann, Camillo Koelblinger, Klaus Vander, Ute Bargfrieder, Michael Trauner,

... or consultant and/or advisory board member for Albireo, BiomX, Boehringer Ingelheim, Bristol-Myers Squibb, Falk, Genfit, ... Intercept, as well as grants/research support from Albireo, Cymabay, Falk, Gilead, Intercept, MSD, and Takeda. He ...

Tópico(s): Liver Disease Diagnosis and Treatment

2020 - RELX Group (Netherlands) | SSRN Electronic Journal

Carta Acesso aberto Revisado por pares

Caroline X. Qin, Scott R. Auerbach, Olga Charnaya, Lara Danziger‐Isakov, Noelle H. Ebel, Amy G. Feldman, Evelyn Hsu, John McAteer, Saeed Mohammad, Emily R. Perito, Ashley M. Thomas, Teresa Po‐Yu Chiang, Jacqueline Garonzik‐Wang, Dorry L. Segev, Douglas Mogul,

... research agreements paid to her institution: Gilead, Mirum, Albireo. Emily R Perito, MD, has the following financial ... clinical research agreements paid to her institution: Gilead, Albireo. Dorry L. Segev, MD, PhD, has the following ...

Tópico(s): COVID-19 Clinical Research Studies

2021 - Elsevier BV | American Journal of Transplantation

Carta Acesso aberto Revisado por pares

Caroline X. Qin, Scott R. Auerbach, Olga Charnaya, Lara Danziger‐Isakov, Noelle H. Ebel, Amy G. Feldman, Evelyn Hsu, John McAteer, Saeed Mohammad, Emily R. Perito, Ashley M. Thomas, Teresa Po‐Yu Chiang, Jacqueline Garonzik‐Wang, Dorry L. Segev, Douglas Mogul,

... Feldman MD has the following disclosures: consulting for Albireo. Evelyn K. Hsu MD has the following disclosures: ... research agreements paid to her institution: Gilead, Mirum, Albireo. Saeed Mohammad MD has the following disclosures: consulting for Albireo and Mirum. Emily R. Perito MD has the ... clinical research agreements paid to her institution: Gilead, Albireo. Dorry L. Segev MD PhD has the following ...

Tópico(s): Viral gastroenteritis research and epidemiology

2022 - Elsevier BV | American Journal of Transplantation

Carta Acesso aberto Revisado por pares

W. G. Brydon, Julian R.F. Walters, Subrata Ghosh, Pearl Culbert,

... a speaker, consultant and advisory board member for Albireo, GE Healthcare, Intercept, Novartis and Pendopharm, and has received research funding from Albireo and Intercept.

Tópico(s): Pediatric Hepatobiliary Diseases and Treatments

2016 - Wiley | Alimentary Pharmacology & Therapeutics

Artigo Acesso aberto Revisado por pares

Magnus Simrén, Lena Öhman, Julie Olsson, Ulla Svensson, K. Ohlson, Iris Posserud, Hans Strid,

... as a speaker or advisor for AstraZeneca, Novartis, Albireo, Danone, Movetis Addex and Succampo, and has received ...

Tópico(s): Infant Health and Development

2010 - Wiley | Alimentary Pharmacology & Therapeutics

Artigo Acesso aberto

Masahiro Nishihara, Takashi Nakatsuka, Keizo Hosokawa, Takahide Yokoi, Yoshiko Abe, Kei‐ichiro Mishiba, Saburo Yamamura,

... was transformed into an interspecific hybrid gentian (cv. Albireo; G. scabra×G. triflora). The vector also contained ...

Tópico(s): Plant biochemistry and biosynthesis

2006 - Japanese Society for Plant Biotechnology | Plant Biotechnology

Artigo Revisado por pares

Brian G. Feagan, Paul Rutgeerts, Bruce E. Sands, William J. Sandborn, Jean–Frédéric Colombel, Stephen B. Hanauer, Gert Van Assche, Jeffrey Axler, Hyo Jong Kim, Silvio Danese, Irving H. Fox, Catherine Milch, Serap Sankoh, Tim Wyant, Jing Xu, Asit Parikh,

... Pharm., Tioga Pharm, Serono, Genentech, Tillotts, Unity Pharmaceuticals, Albireo Pharma, Given Imaging Inc., Salix Pharm., Ore Pharm. ( ...

Tópico(s): Biosimilars and Bioanalytical Methods

2012 - Lippincott Williams & Wilkins | The American Journal of Gastroenterology

Artigo Revisado por pares

WJ Sandborn, B. Feagan, C Gasink, Jürgen M. Stein, L-L Gao, Jewel Johanns, Bruce E. Sands, S. B. Hanauer, Stephan R. Targan, Subrata Ghosh, W de Villiers, Colombel Jf, Shin‐Da Lee, Levinus A. Dieleman, Seymour Katz, P. Rutgeerts,

... UCB Pharma, Consultant for: Abbott/AbbVie, Actogenix, Akros, Albireo Pharma, Amgen, Astra Zeneca, Avaxia Biologics Inc., Avir ...

Tópico(s): Acute Lymphoblastic Leukemia research

2016 - BMJ | Gut

Artigo Acesso aberto Revisado por pares

Claudia Fuchs, Philipp Schwabl, Thomas Reiberger, Michael Trauner,

... He consults and received grants from Intercept and Albireo. He is on the speakers' bureau and received ...

Tópico(s): Pediatric Hepatobiliary Diseases and Treatments

2016 - Lippincott Williams & Wilkins | Hepatology

Artigo Revisado por pares

Keizo Hosokawa, Eri Fukushi, Jun Kawabata, Chiharu Fujii, Tetsuo Ito, Saburo Yamamura,

... isolated from the blue flowers of Gentiana cv. Albireo, along with two known anthocyanins, gentiodelphin and gentiocyanin ...

Tópico(s): Phytochemicals and Antioxidant Activities

1997 - Elsevier BV | Phytochemistry

Artigo Acesso aberto Revisado por pares

Cara L. Mack, David H. Adams, David N. Assis, Nanda Kerkar, Michael P. Manns, Marlyn J. Mayo, Simon C. Ling, Mouaz Alsawas, M. Hassan Murad, Albert J. Czaja,

... Potential conflict of interest: Dr. Mack consults for Albireo. Dr. Kerkar advises High Tide and received royalties ...

Tópico(s): Hepatitis B Virus Studies

2019 - Lippincott Williams & Wilkins | Hepatology

Carta Acesso aberto Revisado por pares

Hanns‐Ulrich Marschall,

... support from Intercept, and non-financial support from Albireo, outside the area of work commented on here. ...

Tópico(s): Pregnancy and Medication Impact

2019 - Elsevier BV | The Lancet

Carta Revisado por pares

A. S. Knisely, Roderick H.J. Houwen,

... reuptake inhibitors. Roderick Houwen was a consultant for Albireo.

Tópico(s): Liver Diseases and Immunity

2020 - Lippincott Williams & Wilkins | Journal of Pediatric Gastroenterology and Nutrition

Carta Acesso aberto Revisado por pares

Amedeo Lonardo, Fernando Bril, Stephen H. Caldwell, Mohammed Eslam, Jian‐Gao Fan, Robert G. Gish, Henning Grønbæk, Sanal Madhusudana Girija, Norbert Stefan, Ayako Suzuki, Giovanni Targher, Herbert Tilg, Ming‐Lung Yu, Ming‐Hua Zheng, Jacob George,

... in the last two years): Abacus, Abbott, AbbVie, Albireo, Aligos, Altimunne, Antios, Arrowhead, AstraZeneca, Audentes Therapeutics, Corcept, ...

Tópico(s): Hepatitis C virus research

2024 - Elsevier BV | Journal of Hepatology

Carta Acesso aberto Revisado por pares

Pier Luigi Calvo, Laura Giugliano, Andrea Evangelista, Elisabetta Bignamini, Michele Pinon,

... produce this manuscript. Calvo PL is consultant for Albireo, Mirum and Nestlè. Giugliano L, Evangelista A, Bignamini ...

Tópico(s): Infant Nutrition and Health

2023 - Elsevier BV | Journal of Hepatology

Revisão Acesso aberto Revisado por pares

Emma D. Deeks,

... the ileal bile acid transporter being developed by Albireo Pharma, Inc. for the treatment of various cholestatic ...

Tópico(s): Drug Transport and Resistance Mechanisms

2021 - Adis, Springer Healthcare | Drugs

Carta Acesso aberto Revisado por pares

Niklas Heucke, Verena Keitel,

... AstraZeneca and is on the speakers' bureau for Albireo, Falk, AbbVie, Gilead, CSL Behring, and Intercept.

Tópico(s): Liver Disease and Transplantation

2022 - Lippincott Williams & Wilkins | Hepatology

Carta Revisado por pares

Katharina Staufer, Brian Mangal, Michael Trauner,

... of Versantis AG. MT discloses grant support from Albireo, Alnylam, Cymabay, Falk, Gilead, Intercept, MSD, Takeda and UltraGenyx, honoraria for consulting from Abbvie, Albireo, BiomX, Boehringer Ingelheim, Falk, Genfit, Gilead, Hightide, Intercept, ...

Tópico(s): Diet, Metabolism, and Disease

2022 - Elsevier BV | Journal of Hepatology

Carta Acesso aberto Revisado por pares

Hanns‐Ulrich Marschall, Fredrik Bäckhed,

... interest: Dr. Backhed consults and received grants from Albireo. He owns stock and holds intellectual property rights ...

Tópico(s): Pediatric Hepatobiliary Diseases and Treatments

2015 - Lippincott Williams & Wilkins | Hepatology

Artigo Revisado por pares

William J. Sandborn, Jean–Frédéric Colombel, Kathleen G. Lomax, Paul Pollack, Roopal Thakkar, Anne Camez, Naijun Chen, Mei Yang, Jingdong Chao, Parvez Mulani,

... employer, Mayo Clinic), ActoGeniX, AGI Therapeutics, Alba Therapeutics, Albireo, AM-Pharma, Amgen, Ardea Biosciences, Aspreva, Astellas, Athersys, ... Colombel: Advisory Boards and/or Consulting: Abbott, ActoGeniX, Albireo Pharma, Astra Zeneca, Bayer Schering Pharma, Biogen Idec, ...

Tópico(s): Eosinophilic Esophagitis

2010 - Lippincott Williams & Wilkins | The American Journal of Gastroenterology

Artigo Acesso aberto

Mizuki Murakami, Yoshiki Koda,

... shares following features with the type species of Albireo: having the large aperture for the cochlear aqueduct; ...

Tópico(s): Cephalopods and Marine Biology

2013 - | Japan Cetology